Literature DB >> 25196780

An improved method for simple, assumption-free ordinal analysis of the modified Rankin Scale using generalized odds ratios.

Leonid Churilov1, Sarah Arnup, Hayden Johns, Tiffany Leung, Stuart Roberts, Bruce C V Campbell, Stephen M Davis, Geoffrey A Donnan.   

Abstract

BACKGROUND AND
PURPOSE: Developing improved methods for analysis of the modified Rankin Scale (mRS) remains a critical issue for the stroke research community. A recently proposed permutation-based approach is assumption-free and easily interpretable but computationally intensive and does not provide confidence intervals to quantify the precision of the effect size estimate. We aimed to develop a method to overcome these limitations.
METHODS: We propose a procedure using generalized odds ratios to estimate the odds that a patient who received the investigational treatment will have a better outcome than a patient receiving standard treatment. This approach was validated against the permutation method using hypothetical clinical trial scenarios of neuroprotective effect, early recanalization effect, late recanalization effect, and random benefit.
RESULTS: The generalized odds ratio approach had strong agreement with the permutation approach provided sample size was >15 patients per treatment arm. Simulation established that the confidence intervals generated were accurate. Ignoring patient pairs with tied mRS scores overestimates the treatment effect compared with splitting tied mRS scores.
CONCLUSIONS: In addition to all the advantages of the recently proposed permutation-based approach, our method generates confidence intervals without the need for intensive computational power. The resulting generalized odds ratios are particularly suitable for inclusion in meta-analyses and have a simple and intuitive connection with the number-needed-to-treat measure.
© 2014 World Stroke Organization.

Entities:  

Keywords:  clinical trial; epidemiology; outcome and process assessment; randomized controlled trials; statistical analysis; stroke

Mesh:

Year:  2014        PMID: 25196780     DOI: 10.1111/ijs.12364

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  18 in total

Review 1.  Physiotherapy interventions for the treatment of spasticity in people with spinal cord injury: a systematic review.

Authors:  Paulo Henrique Ferreira de Araujo Barbosa; Joanne V Glinsky; Emerson Fachin-Martins; Lisa A Harvey
Journal:  Spinal Cord       Date:  2021-02-09       Impact factor: 2.772

2.  Stroke Treatment Academic Industry Roundtable Recommendations for Individual Data Pooling Analyses in Stroke.

Authors:  Kennedy R Lees; Pooja Khatri
Journal:  Stroke       Date:  2016-07-12       Impact factor: 7.914

Review 3.  How to Measure Recovery? Revisiting Concepts and Methods for Stroke Studies.

Authors:  Marc Hommel; Olivier Detante; Isabelle Favre; Emmanuel Touzé; Assia Jaillard
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

4.  Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke.

Authors:  Maarten G Lansberg; Soren Christensen; Stephanie Kemp; Michael Mlynash; Nishant Mishra; Christian Federau; Jenny P Tsai; Sun Kim; Raul G Nogueria; Tudor Jovin; Thomas G Devlin; Naveed Akhtar; Dileep R Yavagal; Diogo Haussen; Seena Dehkharghani; Roland Bammer; Matus Straka; Greg Zaharchuk; Michael P Marks; Gregory W Albers
Journal:  Ann Neurol       Date:  2017-06-09       Impact factor: 10.422

5.  Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.

Authors:  Bruce C V Campbell; Peter J Mitchell; Leonid Churilov; Nawaf Yassi; Timothy J Kleinig; Richard J Dowling; Bernard Yan; Steven J Bush; Vincent Thijs; Rebecca Scroop; Marion Simpson; Mark Brooks; Hamed Asadi; Teddy Y Wu; Darshan G Shah; Tissa Wijeratne; Henry Zhao; Fana Alemseged; Felix Ng; Peter Bailey; Henry Rice; Laetitia de Villiers; Helen M Dewey; Philip M C Choi; Helen Brown; Kendal Redmond; David Leggett; John N Fink; Wayne Collecutt; Thomas Kraemer; Martin Krause; Dennis Cordato; Deborah Field; Henry Ma; Bill O'Brien; Benjamin Clissold; Ferdinand Miteff; Anna Clissold; Geoffrey C Cloud; Leslie E Bolitho; Luke Bonavia; Arup Bhattacharya; Alistair Wright; Abul Mamun; Fintan O'Rourke; John Worthington; Andrew A Wong; Christopher R Levi; Christopher F Bladin; Gagan Sharma; Patricia M Desmond; Mark W Parsons; Geoffrey A Donnan; Stephen M Davis
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

6.  Perfusion profile evaluated by severity-weighted multiple Tmax strata predicts early neurological deterioration in minor stroke with large vessel occlusion.

Authors:  Dong-Seok Gwak; WooChan Choi; Jung-A Kwon; Dong-Hyun Shim; Yong-Won Kim; Yang-Ha Hwang
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-24       Impact factor: 6.960

7.  Hypothermia revisited: Impact of ischaemic duration and between experiment variability.

Authors:  Sarah Sj Rewell; Amy L Jeffreys; Steven A Sastra; Susan F Cox; John A Fernandez; Elena Aleksoska; H Bart van der Worp; Leonid Churilov; Malcolm R Macleod; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-13       Impact factor: 6.200

8.  Analysis of the Modified Rankin Scale in Randomised Controlled Trials of Acute Ischaemic Stroke: A Systematic Review.

Authors:  Aimie Nunn; Philip M Bath; Laura J Gray
Journal:  Stroke Res Treat       Date:  2016-03-20

9.  The Missing Medians: Exclusion of Ordinal Data from Meta-Analyses.

Authors:  Toby B Cumming; Leonid Churilov; Emily S Sena
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

10.  Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trials.

Authors:  Sarah S J Rewell; Leonid Churilov; T Kate Sidon; Elena Aleksoska; Susan F Cox; Malcolm R Macleod; David W Howells
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.